Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Regional Analysis

6.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue 2019-2028 (US$ Million)

6.3 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast Analysis

7. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Organization Size

7.1 Small and Medium Organizations and Large Organizations

7.1.1 Overview
7.1.2 Small and Medium Organizations and Large Organizations: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Offerings

8.1 Products

8.1.1 Overview
8.1.2 Products: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Platforms

8.2.1 Overview
8.2.2 Platforms: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Services

8.3.1 Overview
8.3.2 Services: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Application

9.1 Product Design and Discovery

9.1.1 Overview
9.1.2 Product Design and Discovery: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Product Development

9.2.1 Overview
9.2.2 Product Development: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Pre-Clinical Targeting

9.3.1 Overview
9.3.2 Pre-Clinical Targeting: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Assessment of Drugs and Other Biomedical Products

9.4.1 Overview
9.4.2 Assessment of Drugs and Other Biomedical Products: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Clinical Indication

10.1 Cardiovascular Diseases

10.1.1 Overview
10.1.2 Cardiovascular Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Neurodegenerative Diseases

10.2.1 Overview
10.2.2 Neurodegenerative Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Oncology

10.3.1 Overview
10.3.2 Oncology: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.4 Rare Diseases

10.4.1 Overview
10.4.2 Rare Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.5 Metabolic Diseases

10.5.1 Overview
10.5.2 Metabolic Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.6 Immune Based Diseases

10.6.1 Overview
10.6.2 Immune Based Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.7 Infectious Diseases

10.7.1 Overview
10.7.2 Infectious Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.1.2 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.1.3 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.1.4 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.2 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.2.2 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.2.3 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.2.4 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.3 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.3.2 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.3.3 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.3.4 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.4 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.4.2 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.4.3 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.4.4 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.5 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.5.2 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.5.3 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.5.4 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.6 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.6.2 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.6.3 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.6.4 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 InSilicoTrials Technologies

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Feops

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 CADFEM Medical GmbH

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Dassault Systèmes SE

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Virtonomy GmbH

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Certara Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Computational Life

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 NOVA

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 TwInsight Medical

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Ansys, Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Synopsys, Inc.

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Sensyne Health plc.

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 Cerner Corporation

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market